Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mensa

Showing results (191-200 of 253) with videos related to

Pageof 26
Sort By:
Plos One|August 6, 2016
Resistance Analyses of HCV NS3/4A Protease and NS5B Polymerase from Clinical Studies of Deleobuvir and FaldaprevirKristi L Berger, Christoph Sarrazin, David R Nelson, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|July 25, 2000
[Guidelines for empirical antibiotic treatment of intraabdominal infections. Spanish Society of Chemotherapy]L A Rocha, J R Azanza, J L Balibrea, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 9, 2016
The efficacy of fidaxomicin in the treatment of Clostridium difficile infection in a real-world clinical setting: a Spanish multi-centre retrospective cohortC Fehér, E Múñez Rubio, P Merino Amador, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 6, 2007
Impact of early central venous catheter removal on outcome in patients with candidaemiaD Rodriguez, B J Park, B Almirante, et al.
Antimicrobial Agents and Chemotherapy|August 1, 2018
Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical TrialsPreethi Krishnan, Tami Pilot-Matias, Gretja Schnell, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 30, 2014
Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b studyStefan Zeuzem, Jean-François Dufour, Maria Buti, et al.
Acta Otorrinolaringologica Espanola|October 22, 2003
[Diagnosis and antimicrobial treatment for sinusitis]J A García Rodríguez, J E García Sánchez, M Gobernado Serrano, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|November 26, 2008
[Guidelines for the treatment on infections caused by methicillin-resistant Staphylococcus aureus]J Mensa, J Barberán, P Llinares, et al.
Journal of Gastroenterology|March 15, 2019
Integrated analysis of 8-week glecaprevir/pibrentasvir in Japanese and overseas patients without cirrhosis and with hepatitis C virus genotype 1 or 2 infectionAtsushi Naganuma, Kazuaki Chayama, Kazuo Notsumata, et al.
The Pediatric Infectious Disease Journal|January 1, 2014
Steady-state pharmacokinetics of nevirapine extended-release tablets in HIV-1-infected children and adolescents: an open-label, multiple-dose, cross-over studyCarlo Giaquinto, Gabriel Anabwani, Cornelia Feiterna-Sperling, et al.
Pageof 26

Showing results (191-200 of 253) with videos related to

Sort By:
Pageof 26
Plos One|August 6, 2016
Resistance Analyses of HCV NS3/4A Protease and NS5B Polymerase from Clinical Studies of Deleobuvir and FaldaprevirKristi L Berger, Christoph Sarrazin, David R Nelson, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|July 25, 2000
[Guidelines for empirical antibiotic treatment of intraabdominal infections. Spanish Society of Chemotherapy]L A Rocha, J R Azanza, J L Balibrea, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 9, 2016
The efficacy of fidaxomicin in the treatment of Clostridium difficile infection in a real-world clinical setting: a Spanish multi-centre retrospective cohortC Fehér, E Múñez Rubio, P Merino Amador, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 6, 2007
Impact of early central venous catheter removal on outcome in patients with candidaemiaD Rodriguez, B J Park, B Almirante, et al.
Antimicrobial Agents and Chemotherapy|August 1, 2018
Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical TrialsPreethi Krishnan, Tami Pilot-Matias, Gretja Schnell, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 30, 2014
Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b studyStefan Zeuzem, Jean-François Dufour, Maria Buti, et al.
Acta Otorrinolaringologica Espanola|October 22, 2003
[Diagnosis and antimicrobial treatment for sinusitis]J A García Rodríguez, J E García Sánchez, M Gobernado Serrano, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|November 26, 2008
[Guidelines for the treatment on infections caused by methicillin-resistant Staphylococcus aureus]J Mensa, J Barberán, P Llinares, et al.
Journal of Gastroenterology|March 15, 2019
Integrated analysis of 8-week glecaprevir/pibrentasvir in Japanese and overseas patients without cirrhosis and with hepatitis C virus genotype 1 or 2 infectionAtsushi Naganuma, Kazuaki Chayama, Kazuo Notsumata, et al.
The Pediatric Infectious Disease Journal|January 1, 2014
Steady-state pharmacokinetics of nevirapine extended-release tablets in HIV-1-infected children and adolescents: an open-label, multiple-dose, cross-over studyCarlo Giaquinto, Gabriel Anabwani, Cornelia Feiterna-Sperling, et al.
Pageof 26